有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Elocalcitol;Ro-26-9228;BXL-628
Chemical Name (23E)-1alpha-Fluoro-25-hydroxy-16,17,23,24-tetradehydro-26,27-bishomo-20-epivitamin D3
CAS 199798-84-0
Related CAS
Formula C29H43FO2
Structure
Formula Weight 442.66326
Stage II 期临床
Company Roche Bioscience (Originator)
Activity/Mechanism Bone Diseases, Treatment of, METABOLIC DRUGS, Treatment of Osteoporosis, Vitamin D Analogs
Syn. Route 2
Route 1
the indenone intermediate (xiii) has been obtained as follows: the silylation of 3-methyl-1-pentyn-3-ol (i) with tes-cl and dmap in dmf gives the silyl ether (ii), which is condensed with paraformaldehyde and n-buli in thf to yield the propargyl alcohol (iii). partial reduction of (iii) with red-al in thf affords the allyl alcohol (iv), which is treated with ts-cl and dmap in dichloromethane to provide the allyl chloride (v). the condensation of (v) with the unsaturated ester (vi) (obtained by wittig condensation of perhydroindanone (vii) with triethyl phosphonoacetate (viii) by means of etona) by means of buli and dicyclohexylamine in hmpa gives the octenoic ester (ix), which is reduced with lialh4, yielding the corresponding primary alcohol (x). the reaction of (x) with tscl and pyridine affords the tosylate (xi), which is reduced with libet3h in thf with simultaneous opening of the epoxide ring to provide the hexahydroindenol (xii). finally, this compound is oxidized with pyridinium dichromate (pdc), yielding the target hexahydroindenone intermediate (xiii).
List of intermediates No.
methyl (1r,2r)-1-hydroxy-7-methoxy-1,2,3,4-tetrahydro-2-naphthalenylcarbamate (viii)
ethyl 2-[7-fluoro-2,3-dioxo-3,4-dihydro-1(2h)-quinoxalinyl]acetate (vii)
4-{[tert-butyl(diphenyl)silyl]oxy}-3-[(methylsulfonyl)amino]phenyl acetate (i)
tert-butyl 2-{[tert-butyl(diphenyl)silyl]oxy}-5-hydroxyphenyl(methylsulfonyl)carbamate (ii)
tert-butyl 2-{[tert-butyl(diphenyl)silyl]oxy}-5-[(2s)oxiranylmethoxy]phenyl(methylsulfonyl)carbamate (iii)
1,4-difluoro-2-(isocyanatomethyl)benzene; 2,5-difluorobenzyl isocyanate (iv)
tert-butyl 4-[(1-{[(2,5-difluorobenzyl)amino]carbonyl}-4-piperidinyl)amino]phenethylcarbamate (v)
4-[4-(2-aminoethyl)anilino]-n-(2,5-difluorobenzyl)-1-piperidinecarboxamide (vi)
3-[(12r,13r,22s,23s)-17-acetyl-12-ethyl-13,18,22,27-tetramethyl-3,5-dioxo-4-oxa-8,24,25,26-tetraazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoic acid (ix)
propyl 3-[(12r,13r,22s,23s)-17-acetyl-12-ethyl-13,18,22,27-tetramethyl-3,5-dioxo-4-oxa-8,24,25,26-tetraazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoate (x)
methyl (9r,10r,19s,20s)-14-acetyl-9-ethyl-2-[(hexylamino)carbonyl]-5,10,15,19-tetramethyl-20-(3-oxo-3-propoxypropyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1~3,6~.1~8,11~.1~13,16~]tetracosa-1,3,5,7,11(23),12,14,16,18(21)-nonaene-4-carboxylate (xi)
methyl (9r,10r,19s,20s)-14-acetyl-9-ethyl-4-[(hexylamino)carbonyl]-5,10,15,19-tetramethyl-20-(3-oxo-3-propoxypropyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1~3,6~.1~8,11~.1~13,16~]tetracosa-1,3,5,7,11(23),12,14,16,18(21)-nonaene-2-carboxylate (xii)
propyl 3-[(12r,13r,22s,23s)-17-acetyl-12-ethyl-4-hexyl-13,18,22,27-tetramethyl-3,5-dioxo-4,8,24,25,26-pentaazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoate (xiii)
Reference 1:
    radinov, r.n.; daniewski, a.r. (f. hoffmann-la roche ag); process for preparing anti-osteoporotic agents. ep 1048661; jp 2000336094 .

Route 2
the reaction of the cyclohexylidene ethanol (xiv) with triphosgene gives the corresponding chloride (xv), which is condensed with diphenylphosphine oxide (xvi) by means of nah in dmf to yield the alkyldiphenylphosphine oxide (xvii) (2). the condensation of (xvii) with the hexahydroindenone intermediate (xiii) by means of buli in thf affords the disilylated precursor (xviii), which is finally deprotected by means of tbaf in thf.
List of intermediates No.
propyl 3-[(12r,13r,22s,23s)-17-acetyl-12-ethyl-4-hexyl-13,18,22,27-tetramethyl-3,5-dioxo-4,8,24,25,26-pentaazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoate (xiii)
propyl 3-[(12r,13r,22s,23s)-12-ethyl-4-hexyl-17-(1-hydroxyethyl)-13,18,22,27-tetramethyl-3,5-dioxo-4,8,24,25,26-pentaazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoate (xiv)
propyl 3-[(12r,13r,22s,23s)-17-(1-bromoethyl)-12-ethyl-4-hexyl-13,18,22,27-tetramethyl-3,5-dioxo-4,8,24,25,26-pentaazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoate (xv)
propyl 3-[(12r,13r,22s,23s)-12-ethyl-4-hexyl-13,18,22,27-tetramethyl-3,5-dioxo-17-vinyl-4,8,24,25,26-pentaazahexacyclo[19.2.1.1~6,9~.1~11,14~.1~16,19~.0~2,7~]heptacosa-1,6,9(27),10,14(26),15,17,19,21(24)-nonaen-23-yl]propanoate (xvii)
4-(3-bromopropyl)-2,6-di(tert-butyl)phenol (xviii)
2,6-di(tert-butyl)-4-[3-(4-nitrophenoxy)propyl]phenol (xvi)
Reference 1:
    batcho, a.d.; bryce, g.f.; hennessy, b.m.; iacobelli, j.a.; uskokovic, m.r. (f. hoffmann-la roche ag); vitamin d3 analogs. ep 0808833; jp 1998045713; us 5939408 .
Reference 2:
    kabat, m.m. (f. hoffmann-la roche ag); phosphinoxide vitamin d precursors. ep 1050537 .

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名艾洛骨化醇;英文名Elocalcitol;Ro-26-9228;BXL-628;CAS[199798-84-0]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
华东地区甲苯行情暂稳
华东地区环氧氯丙烷动态
华北地区甲苯行情暂稳
华中地区甲苯行情暂稳
山东地区三氯甲烷价格
华北地区BDO市场观望整理
山东地区木薯乙醇市场变动不大
华南地区甲苯行情暂稳
东北地区甲苯行情下跌
华中地区甲苯行情暂稳
华南地区己二酸行情小幅调整
山东地区三氯甲烷价格
华北地区BDO市场观望整理
华东地区BDO市场疲态难改
华南地区BDO市场商谈偏弱
华北地区BDO市场观望整理
山东地区辛醇市场气氛清淡
华东地区己二酸市场行情持稳
华北地区丁二烯市场价格窄调
山东地区丙烷市场行情上涨
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明